CalciMedica Inc.

11/15/2024 | Press release | Distributed by Public on 11/15/2024 15:05

Initial Statement of Beneficial Ownership - Form 3

Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person *
Bardin Stephen
2. Date of Event Requiring Statement (Month/Day/Year)
2024-11-13 		3. Issuer Name and Ticker or Trading Symbol
CalciMedica, Inc. [CALC]
(Last) (First) (Middle)
C/O CALCIMEDICA, INC. , 505 COAST S. BLVD, #307
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
Chief Financial Officer /
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
LA JOLLA CA 92037
6. Individual or Join/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security 2. Amount of Securities Beneficially Owned 3. Ownership Form: Direct (D) or Indirect (I) 4. Nature of Indirect Beneficial Ownership
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security 2. Date Exercisable and Expiration Date 3. Title and Amount of Securities Underlying Derivative Security 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) 6. Nature of Indirect Beneficial Ownership
Date Exercisable Expriation Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Bardin Stephen
C/O CALCIMEDICA, INC.
505 COAST S. BLVD, #307
LA JOLLA, CA92037

Chief Financial Officer

Signatures

/s/ John Dunn, Esq., Attorney-in-Fact 2024-11-15
**Signature of Reporting Person Date

Explanation of Responses:

(*) If the form is filed by more than one reporting person, see Instruction 5(b)(v).
(**) Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2023 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. 1/4th of the shares subject to the RSU shall vest on October 1, 2025, and 1/16th of the total shares subject to the RSU shall vest on every three months thereafter over the next three years.
(2) Immediately Exercisable.
(3) 1/4th of the shares subject to the Option shall vest on October 1, 2025, and 1/48th of the total shares subject to the Option shall vest on each monthly anniversary thereafter over the next three years.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.